Cargando…
Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment
The cell wall of Candida albicans is composed largely of polysaccharides. Here we focus on β-glucan, an immunogenic cell-wall polysaccharide whose surface exposure is often restricted, or “masked,” from immune recognition by Dectin-1 on dendritic cells (DCs) and other innate immune cells. Previous r...
Autores principales: | Lin, Jia, Wester, Michael J., Graus, Matthew S., Lidke, Keith A., Neumann, Aaron K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Cell Biology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791122/ https://www.ncbi.nlm.nih.gov/pubmed/26792838 http://dx.doi.org/10.1091/mbc.E15-06-0355 |
Ejemplares similares
-
A computational model for regulation of nanoscale glucan exposure in Candida albicans
por: Wester, Michael J., et al.
Publicado: (2017) -
11g, a Potent Antifungal Candidate, Enhances Candida albicans Immunogenicity by Unmasking β-Glucan in Fungal Cell Wall
por: Huang, Xin, et al.
Publicado: (2020) -
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017) -
Hsp21 Potentiates Antifungal Drug Tolerance in Candida albicans
por: Mayer, François L., et al.
Publicado: (2013) -
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
por: Shinde, Ravikumar B, et al.
Publicado: (2012)